Affiliation:
1. Tianjin University of Chinese Medicine Tianjin China
2. Clinical Pharmacology Department Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine Tianjin China
Abstract
AbstractIschemic stroke (IS) remains one of the leading causes of death and disability in humans. Unfortunately, none of the treatments effectively provide functional benefits to patients with IS, although many do so by targeting different aspects of the ischemic cascade response. The advantages of traditional Chinese medicine (TCM) in preventing and treating IS are obvious in terms of early treatment and global coordination. The efficacy of TCM and its bioactive constituents has been scientifically proven over the past decades. Based on clinical trials, this article provides a review of commonly used TCM patent medicines and herbal decoctions indicated for IS. In addition, this paper also reviews the mechanisms of bioactive constituents in TCM for the treatment of IS in recent years, both domestically and internationally. A comprehensive review of preclinical and clinical studies will hopefully provide new ideas to address the threat of IS.
Reference408 articles.
1. Therapeutic Potential of Neurotrophic Factors and Neural Stem Cells Against Ischemic Brain Injury
2. Effect of combined Chinese and Western medicine therapy on neurological recovery in patients with acute ischemic stroke;Aixiang F.;Journal of Henan University of Chinese Medicine,2019
3. Neuroprotective effect of resveratrol against late cerebral ischemia reperfusion induced oxidative stress damage involves upregulation of osteopontin and inhibition of interleukin‐1beta;Al Dera H.;Journal of Physiology and Pharmacology,2017
4. Dengzhanxixin Injection Ameliorates Cognitive Impairment Through a Neuroprotective Mechanism Based on Mitochondrial Preservation in Patients With Acute Ischemic Stroke
5. Inflammation and Stroke: An Overview
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献